Emergent BioSolutions Inc. (EBS) has 214 open-market insider trades by 27 insiders since 2006. The most active filer is Fuad El-Hibri, Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Fuad El-Hibri | Chairman | — | 46 | $79.0M | 2021-12-03 |
| Robert Kramer | CEOPres | — | 9 | $16.7M | 2023-06-09 |
| Daniel Abdun-Nabi | CEO | — | 14 | $16.4M | 2019-03-04 |
| Adam Havey | VP | — | 21 | $13.1M | 2023-06-09 |
| Louis W. Sullivan | Dir | — | 7 | $12.4M | 2025-04-30 |
| Sue Bailey | Dir | — | 14 | $10.9M | 2021-03-04 |
| Ronald Richard | Dir | — | 19 | $10.5M | 2026-04-30 |
| Zsolt Harsanyi | Chairman | — | 12 | $6.8M | 2026-04-30 |
| Daniel Abdun-Nabi | CEO | — | 7 | $5.6M | 2019-03-04 |
| Jerome M. Hauer | Dir | — | 14 | $4.5M | 2023-05-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Donald W. DeGolyer | Director | Sell | $126K | 2026-10-07 |
| Paul Anthony Williams | VP | Sell | $20K | 2026-10-01 |
| Paul Anthony Williams | VP | Sell | $25K | 2026-07-01 |
| Sujata Tyagi Dayal | Director | Sell | $116K | 2026-05-01 |
| Donald W. DeGolyer | Director | Sell | $130K | 2026-05-01 |
| Kathryn C. Zoon | Director | Sell | $144K | 2026-05-01 |
Companies that share insiders with EBS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Keith Katkin | Director | Sell | $128K | 2026-04-30 |
| Paul Anthony Williams | VP | Sell | $34K | 2026-04-01 |
| Ronald Richard | Director | Sell | $440K | 2025-12-05 |
| Donald W. DeGolyer | Director | Sell | $375K | 2025-11-10 |
| Sujata Tyagi Dayal | Director | Sell | $86K | 2025-11-07 |
| Coleen Glessner | VP | Sell | $306K | 2025-10-07 |
| Kathryn C. Zoon | Director | Sell | $126K | 2025-08-15 |
| Donald W. DeGolyer | Director | Sell | $136K | 2025-08-12 |
| Keith Katkin | Director | Sell | $49K | 2025-05-23 |